- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
February 24th, 2008
A research collaboration of Virtus Techno Innovations, a research and development company associated with Mumbai-based Khandelwal Laboratories, Reliance Life Sciences and SRL Ranbaxy, has succeeded in developing a novel nanotechnology-based Gene Repair Therapy (GRT) that can revolutionise treatments for various chronic diseases such as AIDS, cancer, diabetes etc. Apart from curing diseases, it can also help in reversing the ageing process.
Named as Mitsanika, the new GRT therapy activates dead or inactive genes in human body by using water as a medium to absorb the required minerals and metals that can rejuvenate and activate the genes.
The breakthrough was achieved through mimicking the experience of the fetus while floating in the amniotic fluid, said Dr V K Tripathi, chief executive officer of Virtus, who heads a team of 20 scientists who did the research on GRT for over 11 years.
|Related News Press|
News and information
Simple attraction: Researchers control protein release from nanoparticles without encapsulation: U of T Engineering discovery stands to improve reliability and fabrication process for treatments to conditions such as spinal cord damage and stroke May 28th, 2016
Lifeboat Foundation launches 3 books December 16th, 2015
Hopes of improved brain implants October 1st, 2015
Indefinite Life Extension Activists Organize Online Demonstration February 26th, 2015